marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Homology Medicines Financial Ratios 2011-2024 | FIXX
Annual Financial Ratios Homology Medicines
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-15.3 | -2.0 | -4.0 | -6.5 | -10.1 | - | - | - | - | - | - | - |
P/S |
23.8 | 5.7 | 189.4 | 404.2 | 156.9 | - | - | - | - | - | - | - |
EPS |
-0.1 | -1.7 | -2.8 | -2.5 | -1.9 | -12.1 | - | - | - | - | - | - |
EV (Enterprise Value) |
92.8 M | 127 M | 362 M | 672 M | 604 M | 39.2 M | 24.1 M | - | - | - | - | - |
EBITDA per Share |
-2.3 | -1.58 | -2.9 | -2.46 | -2.11 | - | - | - | - | - | - | - |
EV/EBITDA |
-1.1 | -2.4 | -6.0 | -9.0 | - | - | - | - | - | - | - | |
PEG |
- | 0.17 | 0.28 | 0.37 | - | - | - | - | - | - | - | |
P/B |
0.4 | 1.1 | 2.6 | 2.6 | 3.0 | - | - | - | - | - | - | - |
P/CF |
-0.7 | -1.8 | -5.2 | -5.9 | -8.6 | - | - | - | - | - | - | - |
ROE % |
-2.81 | -56.45 | -65.66 | -40.20 | -29.38 | - | - | - | - | - | - | - |
ROA % |
-2.19 | -45.23 | -48.80 | -33.46 | -22.08 | - | - | - | - | - | - | - |
ROCE % |
-74.89 | -56.56 | -54.03 | -36.87 | -26.35 | - | - | - | - | - | - | - |
Current Ratio |
4.5 | 5.0 | 9.7 | 21.5 | 8.7 | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Homology Medicines
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.46 | -1.42 | - | -40.52 | -16.69 | -0.5 | - | -0.59 | -0.51 | 1.61 | - | -0.54 | -0.54 | -0.02 | - | -0.62 | -0.78 | -0.78 | - | -0.67 | -0.61 | -0.64 | - | -1.95 | -1.95 | -1.95 | - | -2.78 | -2.61 | -2.79 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | -22.2 | -20.3 | -0.47 | - | -0.57 | -0.49 | -0.65 | - | -0.5 | -0.5 | 0.02 | - | -0.58 | -0.75 | -0.77 | - | -0.67 | -0.61 | -0.64 | - | -1.6 | -1.62 | -23.9 | - | -2.75 | -2.5 | -2.29 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-128.90 | -28.66 | -5.95 | -22.08 | -47.18 | -63.36 | 6.35 | -9.06 | -8.34 | -9.82 | -29.53 | -43.93 | -42.92 | -47.37 | -50.46 | -61.92 | -58.98 | -51.11 | -30.85 | -59.15 | -76.00 | -94.14 | -84.91 | -68.37 | -23.52 | 20.00 | 45.84 | 45.84 | 29.29 | 14.08 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-50.53 | -37.13 | -28.02 | -40.86 | -43.69 | -50.48 | 6.56 | -6.70 | -7.12 | -8.68 | -25.50 | -36.20 | -33.65 | -35.27 | -37.50 | -47.04 | -45.88 | -40.93 | -25.68 | -47.13 | -59.04 | -72.03 | -64.35 | -69.10 | -52.39 | -35.31 | -13.15 | -13.15 | -8.40 | -4.04 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-146.34 | -38.41 | -8.03 | -23.75 | -44.45 | -61.33 | -41.63 | -57.07 | -56.79 | -58.61 | -29.60 | -44.02 | -43.01 | -47.62 | -51.26 | -63.36 | -61.04 | -53.65 | -32.64 | -63.16 | -81.58 | -101.28 | -91.56 | -74.67 | -27.25 | 18.57 | 44.09 | 44.09 | 27.20 | 11.89 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.2 | 1.4 | 0.4 | 2.7 | 3.4 | 4.3 | 4.5 | 4.9 | 6.4 | 7.0 | 5.0 | 7.2 | 7.5 | 6.9 | 3.9 | 3.9 | 3.9 | 3.9 | 6.0 | 6.0 | 6.0 | 6.0 | 4.1 | 4.1 | 4.1 | 4.1 | 3.5 | 3.5 | 3.5 | 3.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency